Catalyst Wire Dossier Catalyst Wire Dossier

Relugolix combination tablet

relugolix · Sumitomo Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Relugolix combination tablet, covering 2025-08-06 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis [Phase 3]

See pricing